miRNAs increase the activity of CD8+ T cells and decrease the expression of programmed death ligand 1 (PD-L1) in melanoma, resulting in increased sensitivity to CD8+ T cell-mediated cytotoxicity (27). This evidence concerns the gene CD8A and melanoma.